Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human BTN2A1/Butyrophilin 2A1 Protein
Click to view available options
Quantity:
50 μg
Description
Measured by its binding ability in a functional ELISA. When Recombinant Human BTN2A1 is immobilized at 1 μg/mL (100 μL/well), the concentration of Recombinant Human DC-SIGN/CD209 Fc Chimera (Catalog # 161-DC ) that produces 50% of the optimal binding response is approximately 0.1-0.5 μg/mL.
Specifications
Specifications
Accession Number | Q7KYR7 |
For Use With (Application) | Bioactivity |
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Gene ID (Entrez) | 11120 |
Molecular Weight (g/mol) | M.W. (Observed): 39-44 kDa, reducing conditions; M.W. (theoretical): 25 kDa |
Quantity | 50 μg |
Source | Human embryonic kidney cell, HEK293-derived human BTN2A1 protein Gln29-Ala248, with a C-terminal 6-His tag |
Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
Gene Alias | BK14H9.1, BT2.1, BTF1, BTF1BT2.1butyrophilin BTF1, butyrophilin subfamily 2 member A1, butyrophilin, subfamily 2, member A1, DJ3E1.1, FLJ36567 |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction